We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$39.6B
AUM Growth
+$3.93B
Cap. Flow
+$750M
Cap. Flow %
1.89%
Top 10 Hldgs %
5.74%
Holding
1,868
New
87
Increased
789
Reduced
836
Closed
75

Top Buys

Rank Stock Value
1
PF
Pinnacle Foods, Inc.
PF
+$140M
2
BWA icon
BorgWarner
BWA
+$110M
3
HCA icon
HCA Healthcare
HCA
+$97.3M
4
TXT icon
Textron
TXT
+$94.4M
5
WAB icon
Wabtec
WAB
+$88.8M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Industrials 15.25%
3 Technology 14.39%
4 Consumer Discretionary 9.34%
5 Healthcare 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRVN
1726
DELISTED
Trevena, Inc.
TRVN
$16K ﹤0.01%
4
TLGT
1727
DELISTED
Teligent, Inc
TLGT
$16K ﹤0.01%
+245
New +$17.2K
ACAD icon
1728
Acadia Pharmaceuticals
ACAD
$4.65B
$15K ﹤0.01%
504
+28
+6% +$741
AGEN
1729
Agenus
AGEN
$346M
$15K ﹤0.01%
185
+10
+6% +$982
OMER icon
1730
Omeros
OMER
$937M
$15K ﹤0.01%
+1,522
New +$15.5K
HAIN icon
1731
Hain Celestial
HAIN
$48.7M
$14K ﹤0.01%
361
-13,157
-97% -$493K
WPM icon
1732
Wheaton Precious Metals
WPM
$52.4B
$14K ﹤0.01%
698
ACGN
1733
DELISTED
Aceragen Inc
ACGN
$14K ﹤0.01%
68
+4
+6% +$954
KDNY
1734
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$12K ﹤0.01%
207
+12
+6% +$726
ADXS
1735
DELISTED
Advaxis Inc
ADXS
$10K ﹤0.01%
95
+8
+9% +$1.08K
ADPT
1736
DELISTED
Adeptus Health Inc
ADPT
$10K ﹤0.01%
1,371
-712
-34% -$13.1K
TGTX icon
1737
TG Therapeutics
TGTX
$7.46B
$9K ﹤0.01%
1,978
+111
+6% +$651
CLVS
1738
DELISTED
Clovis Oncology, Inc.
CLVS
$8K ﹤0.01%
185
+11
+6% +$387
DVAX
1739
DELISTED
Dynavax Technologies
DVAX
$6K ﹤0.01%
1,530
+86
+6% +$630
ARWR icon
1740
Arrowhead Research
ARWR
$12.6B
$5K ﹤0.01%
3,537
+197
+6% +$839
CLDX icon
1741
Celldex Therapeutics
CLDX
$3.07B
$5K ﹤0.01%
103
+6
+6% +$341
ESPR
1742
DELISTED
Esperion Therapeutics
ESPR
$3K ﹤0.01%
277
+17
+7% +$202
CEMP
1743
DELISTED
Cempra, Inc.
CEMP
$2K ﹤0.01%
873
+48
+6% +$582
RSP icon
1744
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$1K ﹤0.01%
+10
New +$845
AA icon
1745
Alcoa
AA
$12.4B
-70,375
Closed -$1.72M
ABEV icon
1746
Ambev
ABEV
$47B
-25,298
Closed -$154K
ACWI icon
1747
iShares MSCI ACWI ETF
ACWI
$33.4B
-5,639
Closed -$333K
ASIX icon
1748
AdvanSix
ASIX
$546M
$0 ﹤0.01%
+5
New +$90
AVNS
1749
DELISTED
Avanos Medical
AVNS
-738,575
Closed -$25.6M
BDN
1750
Brandywine Realty Trust
BDN
$546M
-920,877
Closed -$14.4M

Similar funds

Victory Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Victory Capital Management held 1,868 positions worth $39.6B, up 11% from $35.7B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.

Victory Capital Management's Q4 2016 filing shows 87 new, 789 increased, 836 reduced and 75 closed positions. Its largest new stake was Alkermes: 1,286,507 shares worth $71.5M. The largest sale was Sealed Air, an estimated $125M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q4 2016 buy was Alkermes: 1,286,507 shares worth $71.5M.
  • Victory Capital Management added most to Pinnacle Foods, Inc. in Q4 2016, an estimated $140M increase.
  • Victory Capital Management's biggest Q4 2016 reduction was Sealed Air, cutting an estimated $125M.
  • Victory Capital Management fully exited Endurance Specialty Holdings Ltd in Q4 2016, selling an estimated $97.5M.
  • Victory Capital Management's ten largest holdings make up 5.7% of its $39.6B portfolio in Q4 2016.
  • Victory Capital Management opened 87 new positions and closed 75 in Q4 2016.
  • Victory Capital Management's portfolio value rose 11% quarter-over-quarter to $39.6B.

Based on Victory Capital Management's 13F filing for Q4 2016, filed 9 Feb 2017.